 |
 |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
Currently, doctors evaluate a patient's chances of developing cardiovascular disease by examining risk factors, such as cholesterol levels, diabetes, high blood pressure, smoking status, and age. Sometimes doctors use mathematical models to estimate the chance that a person will develop cardiovascular disease in the future. The Framingham risk model is a model that doctors commonly use. The model is useful, but not perfect. Some people who have no risk factors develop cardiovascular disease. Others who have multiple risk factors don't develop disease. Researchers wonder whether adding additional factors, such as CRP, to the Framingham model would improve the ability to estimate a person's chances of developing disease.
SUMMARIES FOR PATIENTS
C-Reactive Protein and Prediction of Risk for Cardiovascular Disease in Women
4 July 2006 | Volume 145 Issue 1 | Page I-19
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.
The summary below is from the full report titled "The Effect of Including C-Reactive Protein in Cardiovascular Risk Prediction Models for Women." It is in the 4 July 2006 issue of Annals of Internal Medicine (volume 145, pages 21-29). The authors are N.R. Cook, J.E. Buring, and P.M. Ridker.
What is the problem and what is known about it so far?
C-reactive protein (CRP) is a blood protein that increases when inflammation is present. Inflammation is involved in the blockages in arteries that lead to cardiovascular disease, such as heart attacks and strokes. High CRP levels are associated with cardiovascular disease. However, just because CRP is associated with the risk for cardiovascular disease does not mean that CRP or inflammation causes cardiovascular disease or that treatments to reduce CRP levels will reduce cardiovascular disease.
Why did the researchers do this particular study?
To compare cardiovascular risk predictions models that do and do not include CRP.
Who was studied?
15,048 women age 45 years and older who were free of cardiovascular disease, cancer, and diabetes at the start of the study.
How was the study done?
At the start of the study, the researchers collected information on cardiovascular risk factors, such as age, blood pressure, smoking status, and diabetes. They also collected blood samples to measure cholesterol and CRP levels. During follow-up, the researchers collected information about health outcomes, including cardiovascular disease. The researchers then compared the ability of models that did and did not include CRP to predict patients' chances of developing cardiovascular disease over the next 10 years.
What did the researchers find?
Age, smoking, and blood pressure were the most powerful predictors of cardiovascular disease. Adding CRP to the models improved the accuracy of estimates of who would develop disease. The improvement was mostly among women who had at least a 5% (5 in 100) chance of developing heart disease over the next 10 years. Among this group, adding CRP to the model improved prediction for 20% (20 in 100) of study women.
What were the limitations of the study?
This study included only women who were generally at low risk for cardiovascular disease. The results might not apply to men.
What are the implications of the study?
This study will inform discussions about the value of incorporating CRP levels into methods of evaluating the risk for cardiovascular disease. However, we do not yet know whether treatments to lower CRP levels reduce cardiovascular disease.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  W. Gu and M. S. Pepe Estimating the capacity for improvement in risk prediction with a marker Biostat., January 1, 2009; 10(1): 172 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M Ridker, N. P. Paynter, N. Rifai, J. M. Gaziano, and N. R. Cook C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men Circulation, November 25, 2008; 118(22): 2243 - 2251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. McGeechan, P. Macaskill, L. Irwig, G. Liew, and T. Y. Wong Assessing New Biomarkers and Predictive Models for Use in Clinical Practice: A Clinician's Guide Arch Intern Med, November 24, 2008; 168(21): 2304 - 2310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Janes, M. S. Pepe, and W. Gu Assessing the Value of Risk Predictions by Using Risk Stratification Tables Ann Intern Med, November 18, 2008; 149(10): 751 - 760. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W.F. Wilson, M. Pencina, P. Jacques, J. Selhub, R. D'Agostino Sr, and C. J. O'Donnell C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study Circ Cardiovasc Qual Outcomes, November 1, 2008; 1(2): 92 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Shah, J. P Casas, J. A Cooper, I. Tzoulaki, R. Sofat, V. McCormack, L. Smeeth, J. E Deanfield, G. D Lowe, A. Rumley, et al. Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts Int. J. Epidemiol., October 17, 2008; (2008) dyn217v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. Surtees, N. W. J. Wainwright, S. M. Boekholdt, R. N. Luben, N. J. Wareham, and K.-T. Khaw Major Depression, C-Reactive Protein, and Incident Ischemic Heart Disease in Healthy Men and Women Psychosom Med, October 1, 2008; 70(8): 850 - 855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Camargo Jr, R. G. Barr, R. Chen, and F. E. Speizer Prospective Study of Inhaled Corticosteroid Use, Cardiovascular Mortality, and All-Cause Mortality in Asthmatic Women Chest, September 1, 2008; 134(3): 546 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ness-Abramof and C. M. Apovian Waist Circumference Measurement in Clinical Practice Nutr Clin Pract, August 1, 2008; 23(4): 397 - 404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Lee, A. S. Go, K. Lindquist, D. Bertenthal, and K. E. Covinsky Chronic Conditions and Mortality Among the Oldest Old Am J Public Health, July 1, 2008; 98(7): 1209 - 1214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Arima, M. Kubo, K. Yonemoto, Y. Doi, T. Ninomiya, Y. Tanizaki, J. Hata, K. Matsumura, M. Iida, and Y. Kiyohara High-Sensitivity C-Reactive Protein and Coronary Heart Disease in a General Population of Japanese: The Hisayama Study Arterioscler. Thromb. Vasc. Biol., July 1, 2008; 28(7): 1385 - 1391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Zethelius, L. Berglund, J. Sundstrom, E. Ingelsson, S. Basu, A. Larsson, P. Venge, and J. Arnlov Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes N. Engl. J. Med., May 15, 2008; 358(20): 2107 - 2116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Tice, S. R. Cummings, R. Smith-Bindman, L. Ichikawa, W. E. Barlow, and K. Kerlikowske Using Clinical Factors and Mammographic Breast Density to Estimate Breast Cancer Risk: Development and Validation of a New Predictive Model Ann Intern Med, March 4, 2008; 148(5): 337 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Stangl, V. Witzel, G. Baumann, and K. Stangl Current diagnostic concepts to detect coronary artery disease in women Eur. Heart J., March 2, 2008; 29(6): 707 - 717. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Emmerich and P. M Ridker Can Fishing for New Genes Catch Patients at Risk of Coronary Artery Disease? Clin. Chem., March 1, 2008; 54(3): 453 - 455. [Full Text] [PDF]
|
|
|
|
|
|
Y. M. Smulders, A. Thijs, and J. W. Twisk New cardiovascular risk determinants do exist and are clinically useful Eur. Heart J., February 2, 2008; 29(4): 436 - 440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gurven, H. Kaplan, J. Winking, C. Finch, and E. M. Crimmins Aging and Inflammation in Two Epidemiological Worlds J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2008; 63(2): 196 - 199. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Pepe, Z. Feng, Y. Huang, G. Longton, R. Prentice, I. M. Thompson, and Y. Zheng Integrating the Predictiveness of a Marker with Its Performance as a Classifier Am. J. Epidemiol., February 1, 2008; 167(3): 362 - 368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R. Cook Statistical Evaluation of Prognostic versus Diagnostic Models: Beyond the ROC Curve Clin. Chem., January 1, 2008; 54(1): 17 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S.H. Kim, H. Ishwaran, E. Blackstone, and M. S. Lauer External Prognostic Validations and Comparisons of Age- and Gender-Adjusted Exercise Capacity Predictions J. Am. Coll. Cardiol., November 6, 2007; 50(19): 1867 - 1875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Grootendorst, D. J. de Jager, V. M. Brandenburg, E. W. Boeschoten, R. T. Krediet, F. W. Dekker, and The NECOSAD Study Group Excellent agreement between C-reactive protein measurement methods in end-stage renal disease patients no additional power for mortality prediction with high-sensitivity CRP Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3277 - 3284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Macleod, C. Metcalfe, G. D. Smith, and C. Hart Does consideration of either psychological or material disadvantage improve coronary risk prediction? Prospective observational study of Scottish men J Epidemiol Community Health, September 1, 2007; 61(9): 833 - 837. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Conen, P. M Ridker, J. E Buring, and R. J Glynn Risk of cardiovascular events among women with high normal blood pressure or blood pressure progression: prospective cohort study BMJ, September 1, 2007; 335(7617): 432 - 432. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Wu, N. Rifai, W. C. Willett, and E. B. Rimm Plasma Fluorescent Oxidation Products: Independent Predictors of Coronary Heart Disease in Men Am. J. Epidemiol., September 1, 2007; 166(5): 544 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ingelsson, E. J. Schaefer, J. H. Contois, J. R. McNamara, L. Sullivan, M. J. Keyes, M. J. Pencina, C. Schoonmaker, P. W. F. Wilson, R. B. D'Agostino, et al. Clinical Utility of Different Lipid Measures for Prediction of Coronary Heart Disease in Men and Women JAMA, August 15, 2007; 298(7): 776 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Browner Predicting Fracture Risk: Tougher Than It Looks IBMS BoneKEy, August 1, 2007; 4(8): 226 - 230. [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Lawson, K. K. Miller, V. A. Mathur, M. Misra, E. Meenaghan, D. B. Herzog, and A. Klibanski Hormonal and Nutritional Effects on Cardiovascular Risk Markers in Young Women J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3089 - 3094. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Meuwese, E. S.G. Stroes, S. L. Hazen, J. N. van Miert, J. A. Kuivenhoven, R. G. Schaub, N. J. Wareham, R. Luben, J. J.P. Kastelein, K.-T. Khaw, et al. Serum Myeloperoxidase Levels Are Associated With the Future Risk of Coronary Artery Disease in Apparently Healthy Individuals: The EPIC-Norfolk Prospective Population Study J. Am. Coll. Cardiol., July 10, 2007; 50(2): 159 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Cao, A. M. Arnold, T. A. Manolio, J. F. Polak, B. M. Psaty, C. H. Hirsch, L. H. Kuller, and M. Cushman Association of Carotid Artery Intima-Media Thickness, Plaques, and C-Reactive Protein With Future Cardiovascular Disease and All-Cause Mortality: The Cardiovascular Health Study Circulation, July 3, 2007; 116(1): 32 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. van der Steeg, P. Steures, M. J. C. Eijkemans, J. D. F. Habbema, P. G. A. Hompes, F. J. Broekmans, P. X. J. M. Bouckaert, P. M. M. Bossuyt, F. van der Veen, B. W. J. Mol, et al. Predictive Value and Clinical Impact of Basal Follicle-Stimulating Hormone in Subfertile, Ovulatory Women J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2163 - 2168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Sacco The 2006 William Feinberg Lecture: Shifting the Paradigm From Stroke to Global Vascular Risk Estimation Stroke, June 1, 2007; 38(6): 1980 - 1987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Ridker C-Reactive Protein and the Prediction of Cardiovascular Events Among Those at Intermediate Risk: Moving an Inflammatory Hypothesis Toward Consensus J. Am. Coll. Cardiol., May 29, 2007; 49(21): 2129 - 2138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M Ridker and B. M. Everett Letter by Ridker and Everett Regarding Article, "The Inflammatory Hypothesis: Any Progress in Risk Stratification and Therapeutic Targets?" Circulation, May 22, 2007; 115(20): e475 - e475. [Full Text] [PDF]
|
|
|
|
|
|
M. Berkwits and E. Guallar Risk Factors, Risk Prediction, and the Apolipoprotein B-Apolipoprotein A-I Ratio Ann Intern Med, May 1, 2007; 146(9): 677 - 679. [Full Text] [PDF]
|
|
|
|
|
|
I. Tzoulaki, G. D. Murray, A. J. Lee, A. Rumley, G. D.O. Lowe, and F. G. R. Fowkes Relative Value of Inflammatory, Hemostatic, and Rheological Factors for Incident Myocardial Infarction and Stroke: The Edinburgh Artery Study Circulation, April 24, 2007; 115(16): 2119 - 2127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Musunuru, R. S. Blumenthal, P. M Ridker, N. R. Cook, D. M. Becker, S. Mora, D. C. Goff Jr., R. H. Fletcher, S. W. Fletcher, G. Mints, et al. Biomarkers for Prediction of Cardiovascular Events N. Engl. J. Med., April 5, 2007; 356(14): 1472 - 1475. [Full Text] [PDF]
|
|
|
|
 |
|
 J. H. Revkin, C. L. Shear, H. G. Pouleur, S. W. Ryder, and D. G. Orloff Biomarkers in the Prevention and Treatment of Atherosclerosis: Need, Validation, and Future Pharmacol. Rev., March 1, 2007; 59(1): 40 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Sattar, H. M. Murray, A. McConnachie, G. J. Blauw, E. L.E.M. Bollen, B. M. Buckley, S. M. Cobbe, I. Ford, A. Gaw, M. Hyland, et al. C-Reactive Protein and Prediction of Coronary Heart Disease and Global Vascular Events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) Circulation, February 27, 2007; 115(8): 981 - 989. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R. Cook Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction Circulation, February 20, 2007; 115(7): 928 - 935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M Ridker, J. E. Buring, N. Rifai, and N. R. Cook Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score JAMA, February 14, 2007; 297(6): 611 - 619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Blumenthal, E. D. Michos, and K. Nasir Further Improvements in CHD Risk Prediction for Women JAMA, February 14, 2007; 297(6): 641 - 643. [Full Text] [PDF]
|
|
|
|
 |
|
 J.W. van der Steeg, P. Steures, M.J.C. Eijkemans, J.D.F. Habbema, P.G.A. Hompes, F.J. Broekmans, H.J.H.M. van Dessel, P.M.M. Bossuyt, F. van der Veen, B.W.J. Mol, et al. Pregnancy is predictable: a large-scale prospective external validation of the prediction of spontaneous pregnancy in subfertile couples Hum. Reprod., February 1, 2007; 22(2): 536 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. de Lemos The Latest and Greatest New Biomarkers: Which Ones Should We Measure for Risk Prediction in Our Practice? Arch Intern Med, December 11, 2006; 166(22): 2428 - 2430. [Full Text] [PDF]
|
|
|
|
 |
|
 CRP's Predictive Usefulness in Women Journal Watch Cardiology, August 9, 2006; 2006(809): 2 - 2. [Full Text]
|
|
|
|
 |
|
 C-Reactive Protein: Not Ready for Population-Wide CVD Risk Assessment Journal Watch (General), July 27, 2006; 2006(727): 1 - 1. [Full Text]
|
|
|
|
|
|
G. Davey Smith, N. Timpson, and D. A. Lawlor C-Reactive Protein and Cardiovascular Disease Risk: Still an Unknown Quantity? Ann Intern Med, July 4, 2006; 145(1): 70 - 72. [Full Text] [PDF]
|
|
Read all Rapid Responses
| ||||||||||||||||||||||||||||||||||||||||||
Article
